However, after stratification of current GLP-1 RA use by cumulative dose, risk of fracture was not decreased in the group with patients who had used on average 15 microgram exenatide equivalent per day for at least 1 year (cumulative dose: ≥5.5 mg exenatide equivalent). Here, GCG is linked to rheumatoid arthritis.